Janus Henderson Group PLC Zai Lab LTD Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Zai Lab LTD stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,813,433 shares of ZLAB stock, worth $131 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,813,433
Previous 6,567,892
41.94%
Holding current value
$131 Million
Previous $172 Million
19.88%
% of portfolio
0.08%
Previous 0.09%
Shares
21 transactions
Others Institutions Holding ZLAB
# of Institutions
177Shares Held
45.6MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$206 Million0.04% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$138 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$125 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$108 Million1.86% of portfolio
-
Morgan Stanley New York, NY2.63MShares$90.4 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.36B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...